Welcome to our dedicated page for Evogene news (Ticker: EVGN), a resource for investors and traders seeking the latest updates and insights on Evogene stock.
Evogene Ltd. (EVGN) is a leader in computational biology, leveraging AI and big data to drive innovation in agriculture, health, and industrial applications. This page provides centralized access to official press releases and verified news about the company’s advancements in predictive biology and strategic initiatives.
Investors and industry stakeholders will find timely updates on product developments, research milestones, and strategic collaborations, including those involving subsidiaries Lavie Bio and Biomica. Track announcements related to MicroBoost AI and GeneRator AI platforms, agricultural bio-inoculants, and castor seed innovations for bio-based industries.
Content spans earnings reports, partnership agreements, regulatory updates, and technology breakthroughs. Bookmark this page to stay informed about Evogene’s progress in enhancing crop productivity, therapeutic discoveries, and sustainable industrial solutions through cutting-edge computational methods.
Evogene (NASDAQ: EVGN) reported its Q1 2024 financial results, showing significant improvements. Revenues increased to $4.2M from $0.6M in Q1 2023, driven by Lavie Bio's licensing agreement with Corteva and AgPlenus's collaboration with Bayer. Net loss reduced to $3.8M from $7.0M in the previous year. Projected 2024 cash usage is expected to decrease by 36% to $8.0M. Ceasing Canonic operations will save $1.5M annually. Key developments include Biomica's Phase 1 trial data presentation, Lavie Bio's new collaborations, and AgPlenus's agreement with Bayer.
Casterra Ag has signed new agreements with seed producers in Africa to meet the growing demand for its elite castor seeds. These agreements will support the production of approximately 500 tons of additional seeds, ensuring the fulfillment of orders received in 2023 by the end of 2024.
Together with previous agreements for 400 tons of seeds announced in February, this move positions Casterra to fulfill both current and future demands. The company leverages Evogene's 'GeneRator AI' technology to develop high-yielding, high-oil castor seeds, important for sustainable biofuel production.
Casterra aims to establish a reliable seed production infrastructure, mitigating production risks and reinforcing its market position in the biofuel industry.
Evogene (Nasdaq: EVGN) announces the release of its first quarter 2024 financial results on May 23, 2024. A conference call is scheduled for 9:00 AM ET to discuss the results. Register in advance to join the call.
FAQ
What is the current stock price of Evogene (EVGN)?
What is the market cap of Evogene (EVGN)?
